Financial statement analysis and common stock valuation
Financial Analyst
Stock Analysis on Net
If you are an investor who values fundamental analysis, you are in the right place. If you need comprehensive financial ratios, read on. You already know that the analysis of financial statements allows you to buy cheap and sell high, now it’s time to put it into practice. Stock Analysis on Net is here for you.
Today, try for free:
Gilead Sciences Inc. (NASDAQ:GILD)
Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Measures how efficiently Gilead Sciences Inc. generates revenues from its investments in fixed or total assets.
Enterprise Value to EBITDA (EV/EBITDA)
To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.
Cash Flow Statement
Quarterly Data
The cash flow statement provides information about Gilead Sciences Inc. cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on Gilead Sciences Inc. balance sheet.
Long-term Trends
Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Liabilities and stockholders’ equity components shown as percentage of total liabilities and stockholders’ equity.
Analysis of Short-term (Operating) Activity Ratios
Evaluates revenues and output generated by the Gilead Sciences Inc. assets. Operating performance ratios describe the relationship between the Gilead Sciences Inc. level of operations and the assets needed to sustain operating activities.
Balance Sheet: Liabilities and Stockholders’ Equity
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
Analysis of Liquidity Ratios
Measures the adequacy of Gilead Sciences Inc. cash resources to meet its near-term cash obligations.
Common-Size Balance Sheet: Assets
Assets components shown as percentage of total assets.
Analysis of Long-term (Investment) Activity Ratios
Measures how efficiently Gilead Sciences Inc. generates revenues from its investments in fixed or total assets.
Income Statement
The income statement (statement of earnings) reports on the performance of Gilead Sciences Inc., the result of its operating activities.
Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
What’s new
Wednesday, April 29, 2026
Microsoft Corp. (NASDAQ:MSFT) quarterly report
for quarterly period ended March 31, 2026
Wednesday, April 29, 2026
Qualcomm Inc. (NASDAQ:QCOM) quarterly report
for quarterly period ended March 29, 2026
Wednesday, April 29, 2026
Abbott Laboratories (NYSE:ABT) quarterly report
for quarterly period ended March 31, 2026
Wednesday, April 29, 2026
SLB N.V. (NYSE:SLB) quarterly report
for quarterly period ended March 31, 2026
Wednesday, April 29, 2026
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) quarterly report
for quarterly period ended March 31, 2026
Tuesday, April 28, 2026
T-Mobile US Inc. (NASDAQ:TMUS) quarterly report
for quarterly period ended March 31, 2026